Nektar Therapeutics (NKTR) Cost of Revenue (2010 - 2024)
Nektar Therapeutics' Cost of Revenue was $7.98 million in Q4 2024, up 9.5% from $7.28 million a year earlier and up 79.9% from the prior quarter.
Powered by 
Analysis
Nektar Therapeutics (NKTR) Cost of Revenue (2010 - 2024) Analysis & Trends
For FY2024, Cost of Revenue at Nektar Therapeutics came in at $30.69 million, down 9.1% from FY2023.
- Cost of Revenue shows a five-year compound annual growth rate of 7.5% (FY2019 to FY2024).
- In earlier years, Cost of Revenue was $33.77 million in FY2023 (+56.1%), $21.64 million in FY2022 (-13.1%), $24.9 million in FY2021 (+27.8%) and $19.48 million in FY2020 (-8.9%).
- Quarterly Cost of Revenue has moved between $3.81 million (Q1 2020) and $12.43 million (Q3 2023) over five years.
- Compared with a year earlier, Cost of Revenue was higher in seven of the last eight quarters, with growth averaging 30.2%.
- The best year-over-year quarter for Cost of Revenue over five years was Q3 2023 (growth of 150.0%); the worst was Q3 2024 (a decline of 64.3%).
- Per Business Quant data, NKTR's Cost of Revenue in the three quarters before Q4 2024 was $4.44 million (Q3 2024), $9.74 million (Q2 2024) and $8.53 million (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Nektar Therapeutics | 1.44 Bn | -328.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 7.98 Mn |
| Sep 30, 2024 | 4.44 Mn |
| Jun 30, 2024 | 9.74 Mn |
| Mar 31, 2024 | 8.53 Mn |
| Dec 31, 2023 | 7.28 Mn |
| Sep 30, 2023 | 12.43 Mn |
| Jun 30, 2023 | 6.99 Mn |
| Mar 31, 2023 | 7.06 Mn |
| Dec 31, 2022 | 6.23 Mn |
| Sep 30, 2022 | 4.97 Mn |
| Jun 30, 2022 | 5.12 Mn |
| Mar 31, 2022 | 5.32 Mn |
| Dec 31, 2021 | 6.16 Mn |
| Sep 30, 2021 | 5.31 Mn |
| Jun 30, 2021 | 7.67 Mn |
| Mar 31, 2021 | 5.76 Mn |
| Dec 31, 2020 | 4.32 Mn |
| Sep 30, 2020 | 5.57 Mn |
| Jun 30, 2020 | 5.77 Mn |
| Mar 31, 2020 | 3.81 Mn |
API Access
Nektar Therapeutics Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=NKTR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "NKTR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=NKTR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();